Chondroitin sulfate proteoglycans are the principal inhibitory component of glial scars, which
form after damage to the adult central nervous system and act as a barrier to regenerating
axons. Recent findings have furthered our understanding of the mechanisms that result in a
failure of regeneration after spinal cord injury and suggest that a multipartite approach will
be required to facilitate long-distance regeneration and functional recovery.